Gheuens Sarah bought AGIO

July 9, 2025 · Form 4 insider transaction

Gheuens Sarah bought 11,914 shares of Agios Pharmaceuticals, Inc. at $25.01 per share, a transaction worth $298.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
11,914
Price
$25.01
Total value
$298.0K
Role
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateJuly 9, 2025
Filing dateJuly 11, 2025
Shares owned after73,185
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR